Promising drug combo targets rare brain tumors in new trial
Disease control
Recruiting now
This study tests whether combining two chemotherapy drugs, teniposide and cisplatin, can shrink or control newly diagnosed central malignant germ cell tumors in the brain. About 40 participants will receive the treatment, and researchers will monitor safety, effectiveness, and lo…
Phase: PHASE2 • Sponsor: Chengcheng Guo • Aim: Disease control
Last updated May 15, 2026 11:57 UTC